|
Delaware
(州或其他管轄範圍
成立公司或組織) |
| |
84-1691173
(I.R.S. Employer
識別碼) |
|
|
Large accelerated filer
|
| |
Accelerated filer
☐
|
| | ||
|
Non-accelerated filer
☐
|
| |
較小的報告公司
☐
|
| | ||
| | | |
Emerging growth company
☐
|
| | | |
| | |
Page
|
| |||
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
有關前瞻性陳述的警示説明
|
| | | | 4 | | |
OUR COMPANY
|
| | | | 6 | | |
THE OFFERING
|
| | | | 8 | | |
RISK FACTORS
|
| | | | 9 | | |
USE OF PROCEEDS
|
| | | | 10 | | |
出售證券持有人
|
| | | | 11 | | |
證券説明
|
| | | | 22 | | |
重要的美國聯邦所得税後果
|
| | | | 33 | | |
PLAN OF DISTRIBUTION
|
| | | | 37 | | |
LEGAL MATTERS
|
| | | | 39 | | |
EXPERTS
|
| | | | 39 | | |
您可以在哪裏找到更多信息
|
| | | | 39 | | |
通過引用併入某些信息
|
| | | | 40 | | |
招股説明書中不要求提供第二部分信息
|
| | | | II-1 | | |
EXHIBIT INDEX
|
| | | | II-2 | | |
SIGNATURES
|
| | | | II-5 | | |
| | |
Number of
Shares of Common Stock Owned Prior to Offering |
| |
Warrants
Owned Prior to Offering |
| |
Number of
Shares of Common Stock Being Offered |
| |
Number of
Warrants Being Offered |
| |
Shares of
Common Stock Owned After the Offered Shares of Common Stock are Sold |
| |
Warrants
Owned After the Offered Warrants are Sold |
| ||||||||||||||||||||||||||||||
銷售證券持有人名稱
|
| |
Number
|
| |
Percent
|
| |
Number
|
| |
Percent
|
| ||||||||||||||||||||||||||||||||||||
隸屬於FMR的實體
LLC(1) |
| | | | 6,450,000 | | | | | | — | | | | | | 6,450,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
附屬於Corvex Management LP的實體(2)
|
| | | | 5,250,000 | | | | | | — | | | | | | 5,250,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Chimetech Holding Ltd(3)
|
| | | | 19,750,000 | | | | | | — | | | | | | 17,500,000 | | | | | | — | | | | | | 2,250,000 | | | | | | * | | | | | | — | | | | | | — | | |
BVF Inc.附屬實體(4)
|
| | | | 1,500,000 | | | | | | — | | | | | | 1,500,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | |
Number of
Shares of Common Stock Owned Prior to Offering |
| |
Warrants
Owned Prior to Offering |
| |
Number of
Shares of Common Stock Being Offered |
| |
Number of
Warrants Being Offered |
| |
Shares of
Common Stock Owned After the Offered Shares of Common Stock are Sold |
| |
Warrants
Owned After the Offered Warrants are Sold |
| ||||||||||||||||||||||||||||||
銷售證券持有人名稱
|
| |
Number
|
| |
Percent
|
| |
Number
|
| |
Percent
|
| ||||||||||||||||||||||||||||||||||||
California Physicians’
Service d/b/a Blue Shield of California(5) |
| | | | 500,000 | | | | | | — | | | | | | 500,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
附屬於
的實體
Arboretum Group, LLC(6) |
| | | | 50,000 | | | | | | — | | | | | | 50,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Ziff Capital Healthcare Ventures-QHEQ,LLC(7)
|
| | | | 2,000,000 | | | | | | — | | | | | | 2,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
藥明生物醫療保健
Venture(8) |
| | | | 3,000,000 | | | | | | — | | | | | | 3,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
屬於T.Rowe Price Associates,Inc.的實體(9)
|
| | | | 1,000,000 | | | | | | — | | | | | | 1,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Naya 1740 Fund Limited(10)
|
| | | | 171,750 | | | | | | — | | | | | | 171,750 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Quantum Partners LP(11)
|
| | | | 188,750 | | | | | | — | | | | | | 188,750 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Nayawood LP(12)
|
| | | | 271,000 | | | | | | — | | | | | | 271,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Naya Master Fund LP(13)
|
| | | | 1,390,000 | | | | | | — | | | | | | 1,390,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Naya Coldwater Master Fund Limited(14)
|
| | | | 478,500 | | | | | | — | | | | | | 478,500 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
附屬於
的實體
Franklin Advisors, Inc.(15) |
| | | | 2,000,000 | | | | | | — | | | | | | 2,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
貝恩資本附屬實體,
LP(16) |
| | | | 2,000,000 | | | | | | — | | | | | | 2,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
ALJ Health Care&Life Science Direct Investment Company Limited(17)
|
| | | | 3,000,000 | | | | | | — | | | | | | 3,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
TBC 222 LLC(18)
|
| | | | 300,000 | | | | | | — | | | | | | 300,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
巖泉資本大師基金LP(19)
|
| | | | 1,000,000 | | | | | | — | | | | | | 1,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
隸屬於Avidity Partners Management(GP)LLC的實體(20)
|
| | | | 1,000,000 | | | | | | — | | | | | | 1,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
山間風險基金,有限責任公司(21)
|
| | | | 200,000 | | | | | | — | | | | | | 200,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Invus Public Equities, L.P.(22)
|
| | | | 4,000,000 | | | | | | — | | | | | | 4,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
LYFE Capital Fund III (Phoenix), L.P.(23)
|
| | | | 750,000 | | | | | | — | | | | | | 750,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
附屬於Arch Venture Partners的實體。(24)
|
| | | | 36,335,375 | | | | | | — | | | | | | 36,335,375 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | |
Number of
Shares of Common Stock Owned Prior to Offering |
| |
Warrants
Owned Prior to Offering |
| |
Number of
Shares of Common Stock Being Offered |
| |
Number of
Warrants Being Offered |
| |
Shares of
Common Stock Owned After the Offered Shares of Common Stock are Sold |
| |
Warrants
Owned After the Offered Warrants are Sold |
| ||||||||||||||||||||||||||||||
銷售證券持有人名稱
|
| |
Number
|
| |
Percent
|
| |
Number
|
| |
Percent
|
| ||||||||||||||||||||||||||||||||||||
Entities affiliated with GV 2019, L.P.(25)
|
| | | | 47,252,687 | | | | | | — | | | | | | 47,252,687 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
附屬於
的實體
Andreessen Horowitz(26) |
| | | | 53,064,157 | | | | | | — | | | | | | 53,064,157 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
納皮亞貿易投資公司(新加坡)私人有限公司(27)
|
| | | | 1,500,000 | | | | | | — | | | | | | 1,500,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
MMF LT, LLC(28)
|
| | | | 500,000 | | | | | | — | | | | | | 500,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Soros Capital LP(29)
|
| | | | 1,334,316 | | | | | | 373,356 | | | | | | 750,000 | | | | | | — | | | | | | 584,316 | | | | | | * | | | | | | 373,356 | | | | | | * | | |
總裁和哈佛大學院士(30)
|
| | | | 750,000 | | | | | | — | | | | | | 750,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
SB Northstar LP(31)
|
| | | | 43,976,000 | | | | | | 800,000 | | | | | | 41,250,000 | | | | | | — | | | | | | 2,726,000 | | | | | | * | | | | | | 800,000 | | | | | | * | | |
Boxer Capital, LLC(32)
|
| | | | 1,000,000 | | | | | | — | | | | | | 1,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Verily Life Sciences LLC(33)
|
| | | | 300,000 | | | | | | — | | | | | | 300,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
附屬於Driehaus Capital Management LLC的實體(34)
|
| | | | 1,510,000 | | | | | | 115,000 | | | | | | 750,000 | | | | | | — | | | | | | 760,000 | | | | | | * | | | | | | 115,000 | | | | | | * | | |
託馬斯·傑斐遜大學(35)
|
| | | | 50,000 | | | | | | — | | | | | | 50,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
隸屬於穆巴達拉投資公司的實體PJSC(36)
|
| | | | 7,500,000 | | | | | | — | | | | | | 7,500,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
NeXTech Invest Ltd.附屬實體(37)
|
| | | | 650,000 | | | | | | — | | | | | | 650,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
凱撒永久集團信託附屬實體(38)
|
| | | | 1,000,000 | | | | | | — | | | | | | 1,000,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Eli Casdin(39)
|
| | | | 56,297,042 | | | | | | 8,110,001 | | | | | | 56,297,042 | | | | | | 8,110,001 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Alexis Borisy(40)
|
| | | | 21,004,499 | | | | | | — | | | | | | 21,004,499 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Melanie Nallicheri(41)
|
| | | | 11,411,392 | | | | | | — | | | | | | 11,411,392 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Jami Rubin(42)
|
| | | | 2,194,500 | | | | | | — | | | | | | 2,194,500 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Eric Hedrick(43)
|
| | | | 752,399 | | | | | | — | | | | | | 752,399 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Sandra Horning(44)
|
| | | | 783,750 | | | | | | — | | | | | | 783,750 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Clive Meanwell(45)
|
| | | | 313,500 | | | | | | — | | | | | | 313,500 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Paul Berns(46)
|
| | | | 627,000 | | | | | | — | | | | | | 627,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Amy Abernethy(47)
|
| | | | 200,000 | | | | | | — | | | | | | 200,000 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Christian Henry(48)
|
| | | | 191,666 | | | | | | 166,666 | | | | | | 191,666 | | | | | | 166,666 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Kwame Owusu-Kesse(49)
|
| | | | 108,334 | | | | | | 83,334 | | | | | | 108,334 | | | | | | 83,334 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Chad Robins(50)
|
| | | | 191,666 | | | | | | 166,666 | | | | | | 191,666 | | | | | | 166,666 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Harlan Robins(51)
|
| | | | 191,666 | | | | | | 166,666 | | | | | | 191,666 | | | | | | 166,666 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
CMLS Holdings III LLC(52)
|
| | | | 16,769,373 | | | | | | 8,110,001 | | | | | | 16,769,373 | | | | | | 8,110,001 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | |
Amount
|
| |||
SEC registration fee
|
| | | $ | 31,628 | | |
Legal fees and expenses
|
| | | | * | | |
會計費和費用
|
| | | $ | * | | |
Miscellaneous
|
| | | | * | | |
Total
|
| | | $ | * | | |
|
Exhibit
|
| |
Description
|
|
| 2.1† | | |
合併協議(參考2021年11月30日提交的S-4表格附件A(文件編號333-259054)合併)。
|
|
| 3.1 | | |
第二次修訂和重新註冊的公司證書(通過參考2021年12月20日提交的8-K表格的附件3.1併入)。
|
|
| 3.2 | | |
修訂和重新修訂的章程(通過參考2021年12月20日提交的Form 8-K的附件3.2併入)。
|
|
| 4.1 | | |
普通股證書樣本(參考2021年10月29日提交的S-4表格(文件編號333-259054)附件4.1併入)。
|
|
| 4.2 | | |
保證協議(參考2021年4月9日提交的Form 8-K中的附件10.1併入)。
|
|
|
5.1**
|
| |
Goodwin Procter LLP的意見。
|
|
| 10.1 | | |
認購協議格式(通過引用附件10.2併入2021年8月5日提交的Form 8-K)。
|
|
| 10.2 | | |
修訂和重新簽署的註冊權協議(通過引用附件10.1併入2021年12月20日提交的Form 8-K)。
|
|
|
Exhibit
|
| |
Description
|
|
| 10.3 | | |
註冊權協議(通過引用附件10.3併入2021年4月9日提交的Form 8-K)。
|
|
| 10.4 | | |
私募認股權證購買協議(通過引用附件10.4併入2021年4月9日提交的Form 8-K)。
|
|
|
23.1**
|
| |
Consent of Ernst & Young LLP
|
|
| 23.2 | | |
Goodwin Procter LLP同意(包含在本協議附件5.1中)。
|
|
| 24.1 | | |
授權書(包括在簽名頁上)
|
|
| 107** | | |
Filing Fee Table
|
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Melanie Nallicheri
Melanie Nallicheri
|
| |
董事首席執行官總裁
(首席執行官) |
| |
February 23, 2023
|
|
|
/s/ Jami Rubin
Jami Rubin
|
| |
Chief Financial Officer
(首席財務官和 首席會計官) |
| |
February 23, 2023
|
|
|
/s/ Alexis Borisy
Alexis Borisy
|
| |
Chairman of the Board
|
| |
February 23, 2023
|
|
|
/s/ Amy Abernethy
Amy Abernethy
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Paul Berns
Paul Berns
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Jorge Conde
Jorge Conde
|
| |
Director
|
| |
February 23, 2023
|
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Kathryn Giusti
Kathryn Giusti
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Sandra Horning
Sandra Horning
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Clive Meanwell
Clive Meanwell
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Samuel Merksamer
Samuel Merksamer
|
| |
Director
|
| |
February 23, 2023
|
|
|
/s/ Krishna Yeshwant
Krishna Yeshwant
|
| |
Director
|
| |
February 23, 2023
|
|